PRINTER'S NO. 774
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No.
654
Session of
2017
INTRODUCED BY YAW, MARTIN, ARGALL, EICHELBERGER, SCAVELLO,
McGARRIGLE, LANGERHOLC, GREENLEAF, COSTA, FOLMER AND
RAFFERTY, MAY 2, 2017
REFERRED TO JUDICIARY, MAY 2, 2017
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
drug overdose response immunity.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 13.7 of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended to read:
Section 13.7. Drug Overdose Response Immunity.--(a) A
person may not be charged and shall be immune from prosecution
for any offense listed in subsection (b) and for a violation of
probation or parole if the person can establish the following:
(1) law enforcement officers only became aware of the
person's commission of an offense listed in subsection (b)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22